⌘K

Login Start Free

Home/Filings/4/0001104659-22-084315

4//SEC Filing

LUCI DAVID P 4

Accession 0001104659-22-084315

CIK 0001736243other

View on SEC.gov Company Profile

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 5:01 PM ET

Size

10.1 KB

Accession

0001104659-22-084315

Insider Transaction Report

Form 4

Period: 2022-07-27

Acurx Pharmaceuticals, Inc.ACXP

DirectorPresident and CEO10% Owner

Transactions

Purchase
Warrants for Common Stock
2022-07-27+19,737→ 19,737 total
Exercise: $3.55From: 2023-01-27Exp: 2024-01-27→ Common Stock (19,737 underlying)
Purchase
Warrants for Common Stock
2022-07-27+19,737→ 19,737 total
Exercise: $3.55From: 2023-01-27Exp: 2028-01-27→ Common Stock (19,737 underlying)
Purchase
Common Stock
2022-07-27$3.80/sh+19,737$75,001→ 1,028,460 total

Holdings

Common Stock
(indirect: By Children)
35,000
Common Stock
(indirect: By Spouse)
15,083

Documents

1 file

4
tm2222169-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Acurx Pharmaceuticals, Inc.

CIK 0001736243

Entity typeother

Related Parties

1

filerCIK 0001271123

Filing Metadata

Form type: 4
Filed: Jul 28, 8:00 PM ET
Accepted: Jul 29, 5:01 PM ET
Size: 10.1 KB

View on SEC.gov